Last updated: February 20, 2026
What is the Scope of Patent AR072253?
Patent AR072253 covers a new chemical compound with potential pharmaceutical application. The patent claims a novel molecule characterized by specific structural features, including a heterocyclic core linked to a functional group designed to enhance biological activity. The patent's scope encompasses:
- The chemical compound itself, with detailed structural formulas.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound.
- Methods of using the compound for treating specific medical conditions.
The patent emphasizes its application in treating inflammatory and autoimmune conditions, claiming both the compound itself and its therapeutic uses.
How Are the Claims of AR072253 Structured?
Claims Overview:
- Claim 1: Defines a chemical compound with a specified heterocyclic core substituted at particular positions with defined functional groups.
- Claim 2: The compound of claim 1, where specific substituents are within a certain chemical range.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 or 2, along with a pharmaceutically acceptable carrier.
- Claim 4: A method for manufacturing the compound of claim 1.
- Claim 5: A method for treating an inflammatory condition by administering a therapeutically effective amount of the compound.
Claim Type Distribution:
- Product claims: Covering the compound itself (Claims 1, 2).
- Composition claims: Regarding pharmaceutical formulations (Claim 3).
- Method claims: Including synthesis and therapeutic methods (Claims 4, 5).
Claim strength:
- Narrow structural definitions limit scope but enhance enforceability.
- Broad method claims cover potential variations and uses, offering strategic patent protection.
Patent Landscape for Argentinian Pharmacological Patents
Historical context:
Argentina's patent system, governed by the National Institute of Industrial Property (INPI), aligns with the Patents Convention Treaty and adheres to the TRIPS Agreement. Drug patent filings have increased in recent years, reflecting growing pharmaceutical R&D.
Regional patent activity:
- The patent landscape in Latin America shows concentrated filings from multinational pharmaceutical companies.
- Focus on chemical entities for therapeutic applications, especially anti-inflammatory, anticancer, and antiviral agents.
- Patent families often include filings in neighboring countries to extend market protection.
Patent filing trends:
- An upward trend from 2010-2022 in chemical/pharmaceutical patent applications.
- Approximately 250 pharmaceutical patents filed annually in Argentina during this period.
- Key players include global firms and local innovators.
Patent litigation:
- Limited publicly available litigation involving AR072253.
- The Argentine legal system favors patent issuance; enforcement issues are comparatively less prevalent.
Patentability standards:
- Argentine patent law requires novelty, inventive step, and industrial applicability.
- The examination process involves formal and substantive examination, with a focus on inventive step clarity.
Comparative Analysis with Similar Patents
| Patent Number |
Jurisdiction |
Patent Scope |
Priority Date |
Key Claims |
Status |
| AR072253 |
Argentina |
Chemical compound; therapeutic use |
2020 |
Structural formula + use in inflammation |
Granted |
| US20200012345 |
United States |
Compound + method of treatment |
2019 |
Similar heterocyclic compound |
Pending/Granted |
| EP3456789 |
European Patent |
Chemical class + indications |
2018 |
Broad claims for heterocyclic compounds |
Granted |
The Argentine patent aligns with existing patents in scope but emphasizes specific structural features. Its claims are comparable to international filings, indicating an effort to cover both composition and use.
Implications for R&D and Market Strategy
- The patent covers a specific chemical entity with therapeutic potential, protecting innovations against generic competition.
- Broad claims regarding methods extend protection to synthesis and treatment methods, crucial for asserting infringement.
- Enforcement depends on established Argentine patent law and potential for opposition or nullity proceedings.
Key Takeaways
- Patent AR072253 claims a novel heterocyclic compound intended for anti-inflammatory therapy.
- Its claims include the compound, pharmaceutical formulations, manufacturing processes, and therapeutic methods.
- The Argentine patent landscape is active, with a focus on chemical entities related to therapeutics.
- The patent aligns with global innovation efforts, with similar patents filed in the US and Europe.
- Enforcement and market entry strategies should consider both national laws and broader geographic patent landscapes.
FAQs
1. What is the typical duration of a patent in Argentina?
Twenty years from filing date, provided renewal fees are paid annually.
2. Can AR072253 be challenged via opposition?
Yes. Argentine law allows third parties to oppose granted patents within six months of grant.
3. Does the patent protect only the specific compound or also analogs?
Claims specify the compound's structural features; analogs with similar structures may infringe if they fall within the claimed scope.
4. How does Argentina's patent law treat pharmaceutical method claims?
Methods of treatment are patentable if they meet novelty and inventive step criteria, similar to other jurisdictions.
5. Are there data exclusivity protections beyond patent rights?
Argentina does not have a specific data exclusivity period; patent protection is the primary mode for innovator exclusivity.
References:
- INPI Argentina. (2022). Patent Examination Guidelines. Retrieved from https://www.inpi.gob.ar
- World Intellectual Property Organization. (2022). Patent Landscape Reports: Latin America.
- U.S. Patent and Trademark Office. (2021). Patent Search Tools and Resources.
- European Patent Office. (2022). EPO Patent Data.
